'Personalised' Skin Cancer Drug Brings Fresh Hope To Malignant Melanoma Sufferers

Could This Breakthrough Drug Beat Skin Cancer?

A "personalised" pill for advanced skin cancer that can extend life has been approved for use in the UK.

The drug, vemurafenib, only works for patients with a specific variant of the BRAF gene.

It was developed after scientists learned that the mutation drives tumour growth in about 50% of patients with malignant melanoma, the most deadly form of skin cancer.

Vemurafenib, taken as four pills twice a day, blocks the cancer-causing form of the gene. A test is available to identify patients who might benefit from the treatment.

In clinical trials vemurafenib increased the life expectancy of patients with advanced disease from 9.6 months to 13.2 months.

The European Commission has now licensed the drug for adults whose cancer is inoperable or has spread, making it available in the UK.

However it will not routinely be offered to NHS without backing from the National Institute for health and Clinical Excellence (Nice) which looks at the cost effectiveness of new treatments.

The ground work which led to the development of vemurafenib was carried out at the Institute of Cancer Research (ICF) and Royal Marsden Hospital in London.

Professor Alan Ashworth, chief executive of the ICF, said: "Advanced melanoma is a devastating disease and new treatments are desperately needed, so it's especially pleasing that patients will now be able to benefit from a drug that we helped develop.

"The success of vemurafenib demonstrates the importance of our approach to developing personalised medicines for cancer.

"Understanding the genetic and molecular causes of cancer helps us to create new, targeted therapies that - as this drug shows - can prove extremely effective."

Each year malignant melanoma affects around 10,000 people in the UK and causes 2,300 deaths. The disease is now the second most common cancer in people aged 15 to 34 in the UK. Once the disease has become advanced and spread to other organs it is hard to treat and life expectancy is short.

Vemurafenib and a second drug launched last year called ipilimumab represent the first major advances in treatment for advanced melanoma in 30 years.

The clinical trials of vemurafenib were led by Dr James Larkin at the Royal Marsden.

Cally Palmer, the hospital's chief executive, said: "This is an important and significant step forward for the treatment of patients with advanced melanoma."

Skin Cancer Breakthroughs
Skin Cancer Breakthroughs(01 of09)
Open Image Modal
(credit:Alamy)
Aspirin Could Protect Women(02 of09)
Open Image Modal
Aspirin may protect women from the most dangerous form of skin cancer, research has shown.The longer a woman takes the painkiller, the lower the risk of melanoma, scientists discovered.Read more here. (credit:Alamy)
Vitamin A 'Could Prevent Skin Cancer'(03 of09)
Open Image Modal
Taking daily vitamin A supplements could protect against deadly melanoma skin cancer, scientists claim.According to researchers from the Kaiser Permanente Northern California Division of Research, a compound found in vitamin A, (Retinol), is vital for protecting against skin cancer. Read the full story here. (credit:Alamy)
Skin Cancer Drug 'Almost Doubles Survival Times' In Patients(04 of09)
Open Image Modal
A twice-daily skin cancer drug almost doubles the survival times of advanced cancer patients, American scientists have discovered.Researchers from the Jonsson Cancer Center at the University of California, found that advanced melanoma cancer sufferers lived on average of 16 months after receiving the vemurafenib drug. Read the full story here. (credit:Alamy)
'Radioactive Paint' Could Cure Skin Cancer Tumours In Two Hours(05 of09)
Open Image Modal
Italian scientists have discovered a new, non-surgical skin cancer treatment using radioactive 'paint' which could save up to 3,000 lives a year - and can be done in as little as two hours. Read the full story here. (credit:Alamy)
Young People 'Encouraged' To Use Sunbeds(06 of09)
Open Image Modal
A cancer charity has warned that four in 10 young people under the age of 25 are being 'encouraged' to use sunbeds by their friends.The Cancer Research UK discovered that 26% of 18 to 24-year olds have been given the push to use sunbeds by friends or a family member when using it for the first time. Read the full story here. (credit:Alamy)
Skin Cancer Tablet That Costs 5p(07 of09)
Open Image Modal
A tablet costing a mere five pence a day could be the key to stopping deadly cancer tumours developing, recent research published in the Cancer Epidemiology, Biomarkers & Prevention has found.Scientists from Ohio State University and Aarhus University Hospital in Denmark looked at the records of 4,000 people battling severe forms of cancer. Read the full story here. (credit:Alamy)
'Encouraging' Skin Cancer Gene Discovered(08 of09)
Open Image Modal
Scientists have said an "encouraging" discovery has been made in the fight against the most dangerous form of skin cancer.A team from the Beatson Institute for Cancer Research in Glasgow said it has proved that a specific gene, P-Rex1, must be present before malignant melanoma can spread in a patient. Read the full story here. (credit:Alamy)
One In Six Women Believe Fake Tan Protects Against Sun Damage(09 of09)
Open Image Modal
Millions of women are putting their lives at risk because of a mistaken belief that a spray tan will protect them from the sun's harmful rays.One in six women believe that fake tan acts like a sunscreen while nearly half think their foundation and make-up provides them with UV protection.Read the full story here. (credit:Alamy)
Scientific Medical Breakthroughs
Skin Cancer Drug Doubles Survival Rate(01 of15)
Open Image Modal
A twice-daily skin cancer drug almost doubles the survival times of advanced cancer patients, American scientists have discovered.Researchers from the Jonsson Cancer Center at the University of California, found that advanced melanoma cancer sufferers lived on average of 16 months after receiving the vemurafenib drug. Read the full story here.Read the full story here (credit:Alamy)
Breakthrough Test Could Predict Heart Attacks And Strokes (02 of15)
Open Image Modal
Scientists have discovered five new genes that cause heart attacks and strokes and hope these findings will enable them to pinpoint when the attacks will strike.The researchers, from Queen Mary University of London, identified five generic variants that trigger heart attacks and strokes after investigating blood pressure measurements of 25,000 participants. The aim of the study was to look into the role that genes play in hypertension and high blood pressure. Read the full story here. (credit:Alamy)
Skin Cancer Pill Brings Fresh Hope To Alzheimer's Sufferers(03 of15)
Open Image Modal
American scientists have discovered a potential new drug that could help fight against Alzheimer's disease.Neuroscientists from the Case Western Reserve University School of Medicine discovered that a skin cancer drug called bexarotene appears to reverse cognitive and memory deficits associated with Alzheimer's when tested on lab mice.Read the full story here. (credit:Alamy)
Personalised Skin Cancer Drugs Brings Fresh Hope(04 of15)
Open Image Modal
A "personalised" pill for advanced skin cancer that can extend life has been approved for use in the UK.The drug, vemurafenib, only works for patients with a specific variant of the BRAF gene.Read the full story here. (credit:Alamy)
Genetic Breakthrough Raises Hope For Breast Cancer Sufferers(05 of15)
Open Image Modal
The genetic code of the most common form of hereditary breast cancer has been mapped for the first time, offering hope for diagnosis and treatment of the disease in the future.Researchers say they have "fully sequenced" the DNA of two breast cancers caused by a faulty BRCA1 gene, which is responsible for aggressive and highly drug-resistant tumours.Read the full story here. (credit:Alamy)
Peanut Allergies - Have Scientists Finally Found A Cure? (06 of15)
Open Image Modal
Scientists from the Northwestern University in Chicago have come one step closer to developing a potential cure for peanut allergies, by creating an immune system tolerant to peanuts. The researchers found that they can switch off potentially deadly peanut allergy attacks by tricking the immune system into tolerating nut proteins, and not seeing them as a threat to the body. Read the full story here. (credit:Alamy)
Lung Cancer Detection Test Trial (07 of15)
Open Image Modal
A breakthrough lung cancer detection test is set to be trialled on smokers for the first time in Scotland.If successful, cancers could be identified five years earlier than by current detection methods.Read the full story here. (credit:Alamy)
Cure For Insomnia A Step Closer After Scientists Discover The Enzyme That Wakes Us Up (08 of15)
Open Image Modal
Sleepless nights could soon be a thing of the past as scientists discover a key chemical trigger that suppresses sleep and wakes people up. Researchers from Boston University found that when the body has too little of the calcium kinase enzyme, it causes the brain to nod off to sleep. Read the full story here. (credit:Alamy)
Boiling Breast Cancer Tumours Kills Them In Minutes, Discover Experts (09 of15)
Open Image Modal
A new treatment for breast cancer has been discovered after scientists found that breast tumours can be killed in minutes - by boiling them. The latest treatment, known as Preferential Radio-Frequency Ablation, uses a targeted electrical current that heats, or 'boils' the tumour to 70 to 90c (160 to 190f). Read the full story here. (credit:Alamy)
New Scan Detects Breast Cancer In Seconds Using Anti-Landmine Technology (10 of15)
Open Image Modal
British scientists have developed a revolutionary breast-screening system that uses anti-landmine technology to detect cancer in seconds. The radio-wave scanner is safer, cheaper and less painful than traditional mammogram X-rays, and unlike the current system, can be used on women of all ages.Read the full story here. (credit:Alamy)
Stem Cell Transplant Offers New Hope For Autism and Parkinson's (11 of15)
Open Image Modal
Breakthrough research involving a brain transplant of stem cells could offer hope for the treatment of both autism and Parkinson's disease.The study, from Harvard University, has already proven successful with mice. Scientists transferred healthy stem cells from mouse embryos into the brains of adult mice who were unable to use leptin, a hormone that tells the body when to stop eating.Read the full story here. (credit:Alamy)
Gastric Pacemaker To Fight Obesity By Convincing Brain That Stomach Is Full (12 of15)
Open Image Modal
A stomach implant that can trick the brain into thinking the stomach is full is the latest hi-tech gadget that experts hope will help fight the flab and beat obesity. The Abiliti, or 'Gastric Pacemaker', is a credit card-sized implant, inserted using keyhole surgery, which detects when food has been eaten and sends signals to the brain to create the feeling of fullness.Read the full story here. (credit:Alamy)
'Fertility Switch' Could Save Women From Pain Of Infertility Or Miscarriage (13 of15)
Open Image Modal
Scientists from the Imperial College London have discovered a 'fertility switch' that could help treat infertility and miscarriage in the future. The study, published in the Nature Medicine journal, discovered an enzyme in the body that determines infertility and the chances of miscarriage, as it acts like a 'switch'. Read the full story here. (credit:Alamy)
New Once-Daily HIV Pill Available In UK (14 of15)
Open Image Modal
Eviplera, a new once-daily pill for the treatment of HIV has been made available in 27 countries of the European Union following approval by the European Medicines Agency. The new drug, from Gilead Sciences, combines three antiretroviral treatments in a single tablet so HIV patients only need to take one tablet a day to treat their condition.Read the full story here. (credit:Alamy)
Potent Alzheimer's Vaccine 'Could Prevent Disease From Developing' (15 of15)
Open Image Modal
Scientists believe that a potent Alzheimer's vaccine jab could be the secret to preventing the disease developing from its early stages. Researchers from Georgetown University Medical Center in Washington found that an antibody for Alzheimer's disease is more likely to trigger inflammation in the brain the later it is given and that it could potentially be prevented, as long as the vaccine is taken during the very early stages of the disease. Read the full story here. (credit:Alamy)